-
597 Reads
|
0 Comments
|
March 19, 2014
Time to focus on milestones/catalysts! PLI has indicated that 2013 revenues are not going to be much different than 2012. Consequently we can expect another loss for 2013. I expect the Big Boys to exploit the situation and try and move the sp down once again to drive out the weak hands.. Of course it will bounce right back up exactly like we are in the process of experiencing from this...
-
378 Reads
|
0 Comments
|
March 18, 2014
bepando User Actions March 18, 2014 - 12:55 PM 218 Reads | Post# 22336476 Rate this post v More From Fred This just came. Bottom line is no company related reason or news for yesterday's activity. *...
-
434 Reads
|
0 Comments
|
March 12, 2014
http://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc?postid=22314936
-
383 Reads
|
0 Comments
|
March 11, 2014
ProMetic Receives $3.2 Million Via Loan Repayment LAVAL, QUEBEC--(Marketwired - March 11, 2014) - ProMetic Life Sciences Inc. (TSX:PLI) (OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that it has received approximately $3.2 million via the repayment of the amended and restated loan entered into in March, 2010 by ProMetic and InvHealth Holding Inc. ("...
-
798 Reads
|
0 Comments
|
March 5, 2014
http://beaconsecurities.ca/research-prometic-life-sciences/Beacon site ProMetic Life Sciences - Time to Re-Assess Value. Raise Target Price to $3.50 Read more at http://www.stockhouse.com/companies/bullboard/t.pli/prometic-life-sciences-inc#TpxvhmjjJCq1O4Rr.99
-
638 Reads
|
0 Comments
|
February 25, 2014
Canaccord Initiates coverage with $2 target Tremendous growth potential with a diversified risk profile: Initiating coverage with a BUY rating and C$2.00 target Investment recommendation We are initiating coverage of ProMetic Life Sciences with a BUY recommendation and a C$2.00 target price. ProMetic is a global biopharmaceutical company that focuses on the manufacturing and development of...
-
295 Reads
|
0 Comments
|
February 6, 2014
ProMetic Enters Into $1.6 Million Development Agreement With New Client LAVAL, QUEBEC--(Marketwired - Feb. 6, 2014) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL"), has entered into a new agreement with a leading vaccines company, for the...
-
222 Reads
|
0 Comments
|
February 6, 2014
ProMetic Enters Into $1.6 Million Development Agreement With New Client LAVAL, QUEBEC--(Marketwired - Feb. 6, 2014) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL"), has entered into a new agreement with a leading vaccines company, for the...